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Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease principally aﬀecting motor neurons. Besides motor
symptoms, a subset of patients develop cognitive disturbances or even frontotemporal dementia (FTD), indicating that
ALS may also involve extramotor brain regions. Both neuropathological and neuroimaging ﬁndings have provided further
insight on the widespread eﬀect of the neurodegeneration on brain connectivity and the underlying neurobiology of motor
neurons degeneration. However, associated eﬀects on motor and extramotor brain networks are largely unknown. Particularly,
neuropathological ﬁndings suggest that ALS not only aﬀects the frontotemporal network but rather is part of a wide
clinicopathological spectrum of brain disorders known as TAR-DNA binding protein 43 (TDP-43) proteinopathies. This
paper reviews the current state of knowledge concerning the neuropsychological and neuropathological sequelae of TDP-43
proteinopathies, with special focus on the neuroimaging ﬁndings associated with cognitive change in ALS.
1.Introduction
Amyotrophic lateral sclerosis (ALS), also known as motor
neuron disease, is a progressive disorder causing degenera-
tion of the motor system at all levels, from the cortex to the
anterior horn of the spinal cord. Approximately 5% of cases
are familial, whereas the bulk of patients diagnosed with the
disease are classiﬁed as sporadic as they appear to occur ran-
domly throughout the population. A large hexanucleotide
repeat expansion in the ﬁrst intron of the C9ORF72 gene
is resulted, the most common genetic cause of familial ALS
(FALS). It was detected in more than one-third of FALS cases
of European ancestry and in nearly one-half of Finnish FALS
cases [1].
Despite the early view of ALS as a neurodegenerative
disease that exclusively aﬀects the motor system, growing
evidence supports the new concept of ALS as a multisystem
diseasealsoaﬀectingexecutivefunctions,behavior,language,
and other cognitive domains, functionally associated, in
general, with temporal and frontal lobes [2, 3]. A detectable,
although variable in magnitude, degree of cognitive involve-
ment has been found in many patients with ALS. Indeed,
5–15% of ALS patients meet criteria for frontotemporal
dementia (FTD), while a substantial percentage of patients
without dementia may show mild to moderate executive
(approximately from 22 to 35%) and behavioral (up to 63%)
dysfunctions [3–5]. In support of these clinical evidences,
immunohistochemical ﬁndings suggest that ALS may aﬀect
the frontotemporal network and, furthermore, is considered
part of a broader clinicopathological spectrum now known
as TAR-DNA binding protein 43 (TDP-43) proteinopathies
which also include FTD [6, 7].2 Neural Plasticity
Structural and functional magnetic resonance imaging
(MRI), positron emission tomography (PET), and single
photon emission-computed tomography (SPECT) studies
have corroborated the theory of frontotemporal impairment
in ALS with approximately half of the patients displaying at
least mild abnormalities [8–25]. In particular, the diﬀusion
tensor imaging (DTI) ﬁndings of reduced white matter
(WM) integrity in the frontal, temporal, and parietal lobes
and in the corpus callosum suggest that a widespread WM
involvement may underlie both cognitive and functional
changes in ALS [17–25].
Asthebrainisacomplexsystemofinteractingstructures,
relevant contributions have been derived from resting-state
functional magnetic resonance imaging (RS-fMRI), a novel
technique that evaluates the spontaneous ﬂuctuations in
the Blood Oxygen Level-Dependent (BOLD) signals with
subjects being completely at rest [26, 27], which proved to
be particularly suitable to explore functional interactions
between cerebral networks in ALS. Indeed, local degener-
ation of motor neurons was found to be accompanied by
a widespread eﬀect on brain networks [21, 22, 28, 29].
A whole body of evidence, including the aforementioned
ones, leads to the novel conception of ALS as a multisystem
disease that aﬀects not only primary motor connections but
also the connectivity between primary motor regions and
supplemental motor and extra-motor regions.
Given that neuropsychological and neuropathological
ﬁndings may be interpreted as the cognitive and histopatho-
logical correlates of disease-related loss of the structural
brain integrity in ALS, with a consequent reorganization of
corticalnetworks,wewillreviewcurrentneuropsychological,
neuropathological, and neuroimaging knowledge within a
framework of cognitive and connectivity changes in ALS,
along with some recent hypotheses about pathogenesis.
2. CognitiveandBehavioral Changes in ALS
It is now recognized that the ALS-dementia (ALS-D) syn-
drome is not a random association. It occurs in at least 5%
of patients with ALS and includes a set of diﬀerent subtypes
[4, 5]. Clinically, the most common syndrome appears to be
very similar to FTD, characterized by personality change,
breakdowninsocialconduct,andimpairmentofabstraction,
planning, set shifting, and organizational skills [2]. Com-
pared to ALS without symptoms of FTD, the prognosis of
ALS with comorbid FTD (ALS-FTD) is more unfavorable,
and the median survival of patients with ALS-FTD is shorter
than that of ALS patients by approximately 1 year [30].
One subgroup of ALS-D patients presents at onset
with a predominantly aphasic syndrome, characterized by
changes in speech (slowing of speech or dysarthria, anomia,
neologisms, echolalia, and semantic paraphasias) [31, 32],
although bulbar involvement in the tongue and throat may
frequently obscure these language-speciﬁc symptoms.
Therefore, patients with ALS can have features of pro-
gressive nonﬂuent aphasia (PNFA), semantic dementia
(often atypical), or both. Verbal ﬂuency has been the most
frequently investigated executive task in ALS research and
has been found to be impaired in the majority of cognitive
studies in ALS (e.g., [2, 8, 13]). Furthermore, a number
of neuropsychological studies have found deﬁcits among
nondementedALSpatientsintasksofconfrontationnaming,
conceptual semantic processing, and syntactic comprehen-
sion [33], in conjunction with paraphasias, decreased phrase
length, and deﬁcits in phrase construction [5, 34].
In comparison to the ﬁndings of impaired executive
functioning, memory abilities are less consistently disrupted
in ALS [34, 35], with poor performance on memory tasks
considered indicative of a failure of encoding information,
again implicating a frontal lobe impairment [30].
Behavioral changes are now recognized as another fea-
ture of ALS [4]. The term behaviorally impaired (ALSbi)
has been recently introduced to describe ALS patients who
display frontal behavioral signs but do not meet the full
criteria for FTD. Thus, according to current consensus crite-
ria [36], diagnosis of ALSbi requires that the patient meets
at least two nonoverlapping supportive diagnostic features
from Hodges’ criteria [37] for FTD. Although cognitively
normal patients with ALS can have profound behavioral
abnormalities, cognitive and behavioral impairments can
coexist in 25% or more of ALS patients [3].
Disinhibition, irritability, emotional blunting, lack of
empathy, and especially apathy have been reported in
several cohorts of ALS patients [38–41]. Although the most
commonly applied instrument to compare the behavioral
changes in several neurodegenerative diseases is the Frontal
Systems Behavior (FrSBe) Scale, which is able to assess apa-
thy, disinhibition, and executive dysfunction [42], additional
investigations are needed to rule out the potential confound-
ing eﬀects of motor impairment, depression, and recall bias
on the evaluation of behavioral modiﬁcations by using this
inconjunctionwithmeasuresofmoodorothersimilarscales
that account for mood and motor weakness [41].
Furthermore, instrumental markers of cognitive and
behavioral impairment in ALS might be useful tools for
disease management, promoting the quality of life of both
patients and caregivers. In this regard, structural imaging
techniques (DTI and voxel-based morphometry, VBM) have
allowed to investigate the neuroanatomical correlates of
some frontal symptoms, like apathy, the most prominent
behavioral feature in ALS [43, 44]. Therefore, in the future,
it will be assessed by longitudinal analyses whether DTI and
VBM measures may have a predictive value as biomarkers of
behavioral impairment in ALS.
3.The Neuropathological Basisof
Cognitive Impairment in ALS
Together with the advancements of research in neuropsy-
chology, neurobiological studies have inferred a relationship
between the density and distribution of pathological abnor-
malitiesandcognitivechangesinbothALSandFTD.Indeed,
by comparing the neuropathologic features of ALS and spo-
radic FTD, a common and characteristic pathologic ﬁnding
has emerged in ALS, the ubiquitin-only inclusion body
(UBI), at the level of spinal anterior horns, hippocampus,Neural Plasticity 3
frontotemporal and parietal neocortices [45, 46], and basal
ganglia [47, 48], showing higher density and more wide-
spread distribution of inclusions in cognitively impaired ALS
patients than in cognitively normal ALS patients [45, 48].
On the basis of these new insights the hypothesis
that a common undiscovered proteinopathy underlays both
sporadic ALS and FTD was formulated. After TDP was
identiﬁed as the main disease protein in the majority of
FTD cases [49], the ubiquitinated compact and skeinlike
inclusions characteristic for ALS were also found to be
composed of TDP-43 [49, 50], thereby providing strong
evidence that ALS and FTD are part of a clinicopathological
continuum of multisystem diseases, the so-called TDP-43
proteinopathies [7]. In fact, immunohistochemical whole-
brain analyses of autopsied ALS/FTD cases revealed TDP-43
deposits in multiple brain areas within and also beyond the
pyramidal motor system, including the nigrostriatal system,
neocortical and allocortical areas, and, to a variable extent,
the cerebellum, although there were regional diﬀerences
in the pathological burden between the various clinical
phenotypes [6, 7]. Moreover, the presence or absence of
cognitive behavioral dysfunction has been associated with
the topographic distribution of cortical TDP-43 inclusions
(i.e., predominant involvement of the frontal gyrus in
patients with behavioral and/or dysexecutive symptoms, and
of the temporal cortex and the angular gyrus in case of
language dysfunction) [6, 7, 51].
Furthermore, cortical involvement with pathological
TDP-43 aggregations was usually accompanied by subcorti-
cal TDP-43 pathology, in particular in areas directly adjacent
to the aﬀected cortex [7]. This ﬁnding points toward an
involvement of subcortical U-ﬁbers, implicated in connec-
ting multiple cortical areas, suggesting that such subcortical
involvement may underlie both cognitive and functional
changes in ALS.
WithintheALS/MND-FTDspectrumdisorders,multiple
genes appear to drive a similar phenotype characterized
by neuroglial inclusions immunoreactive to phosphorylated
TDP-43. Speciﬁcally, mutations in transactivation response
DNA-binding protein (TARDBP) gene and in other genes
associated with neuronal (NCIs) or glial (GCIs) cytoplasmic
inclusions (i.e., fused in sarcoma/translocation in liposar-
coma or FUS/TLS, C9ORF72, and progranulin or PGRN)
have been identiﬁed in several familial or sporadic ALS and
ALS/FTD cases [1, 52], and in subsets of FTD [52, 53].
Remarkably, the availability of well-characterized human
pathologicalmaterialinbrainbankshasyieldedthepotential
to study this disease pathway by creating transgenic animal
models, based on diﬀerent genes but resulting in a common
pathology [54–56].
Neuropathological ﬁndings from human autopsy studies
[51, 57] and experimental models [54–56] of ALS/MND
havealsosuggestedthatneuronal loss is noncellautonomous
and glial cells contribute signiﬁcantly to neurodegeneration
within motor and extra-motor areas. Interestingly, recent
evidence suggests that in ALS/MND cytoplasmic protein
aggregate inclusions occur also in GCIs in multiple areas.
Thisisespeciallytrueforoligodendroglialcells,insomecases
showing a signiﬁcant correlation between the topographic
distributionofGCIsandthediﬀerentclinicalsubsetsofALS-
D[ 56, 58]. However, taking the neuropathological ﬁndings
together, it is clear that the idea of a speciﬁc frontotemporal
dysfunction underlying cognitive impairment in ALS is only
partially valid. Instead, this model should be reﬁned in favor
ofabroadernetworkinvolvingdysfunctioninmultipleareas,
mainly focused on frontotemporal regions that have major
connections with posterior areas as well as subcortical and
limbic structures.
4. FunctionalImagingStudies
The whole-brain analysis of functional brain activity has
undoubtedly played a crucial role towards a better under-
standing of the in vivo pathology of ALS over the last two
decades.
The earliest single photon emission-computed tomogra-
phy (SPECT) with 99mTc-hexamethylpropylene, that indi-
rectly evaluated functional brain activity by measuring the
regional cerebral uptake of glucose, identiﬁed reduced tracer
uptake in the frontal lobes of some patients with ALS-D
[59, 60]. A number of subsequent SPECT studies have also
reported widespread frontotemporal lobe involvement in
ALS patients with or without cognitive impairment [10, 11].
Moreover, to explore the relationship between activation and
cognitive functions, reduction of regional Cerebral Blood
Flow (rCBF) in frontal and temporal areas (anterior and
medial orbitofrontal cortex, anterior and medial frontal
cortex, and anterior temporal lobes) was correlated to
neuropsychological performance, revealing a more marked
and widespread pattern of perfusion impairment in patients
with ALS-FTD (reduction of rCBF also in the posterior
frontal, parietal, and occipital lobes bilaterally) [60, 61]
and a signiﬁcant correlation between memory impairment
(abnormal retrieval processes) and frontal hypoperfusion in
patients with classical ALS [33]. However, not all previous
SPECT studies reported signiﬁcant correlations between
measures of rCBF and neuropsychological data [62], prob-
ably because of the diﬀerent clinical characteristics of the
enrolled patients (variability of onset and clinical course of
the disease, and of the degree of functional and cognitive
impairment) and the diﬀerent methodologies used.
(18F)2-Fluoro-2-deoxy-D-glucose positron emission to-
mography (FDG-PET) studies, assessing regional cerebral
metabolic rates for glucose (rCMRGlc), also found sig-
nificantly decreased rCMRGlc in the frontal cortex and
superior occipital cortex in classical ALS patients compared
to controls, revealing a signiﬁcant correlation between mild
frontal dysfunction and reduced glucose metabolism in the
frontal cortex and thalamus [63].
More recently, Flumazenil PET studies assessed the
regional ﬂumazenil binding to the benzodiazepine subunit
of the Gamma-aminobutyric acid A (GABAA) receptor, as
ap o t e n t i a lm a r k e rf o rc o r t i c a ln e u r o n a ll o s so rd y s f u n c t i o n
[64, 65]. Reduced [11C]-ﬂumazenil binding in ALS, asso-
ciated with poorer oﬄine performance on written verbal
ﬂuency tasks and Graded Naming Test [66], was reported in
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gyrus, and anterior insula [67], in agreement with earlier
neuropathological ﬁndings in ALS-aphasia [31, 32]. Further
evidence of extra-motor involvement in ALS, using [11C]-
ﬂumazenil PET, was also provided by Lloyd et al. [68]w h o
foundsigniﬁcantbilateralreductionsintheprefrontalcortex,
B r o c a ’ sa r e a ,r i g h tt e m p o r a lc o r t e x ,t h ep a r i e t a lc o r t e x ,a n d
right visual association cortex.
In the last two decades, functional activation studies
have proven invaluable in exploring disease-related eﬀects in
ALS patients on the physiologic activity of diﬀerent neural
systems. The development of new acquisition protocols has
allowed the study of the brain, both structurally and func-
tionally, also with the hope of discovering sensitive and
speciﬁc biomarkers for monitoring the progressive extent
of the multisystem degeneration in ALS [69]. However,
given that some conditions like hypoxia and hypercapnia
mightinﬂuencebraincognitiveandfunctionalmodiﬁcations
[70, 71], their confounding eﬀects should be avoided in the
assessment of MRI research projects. Furthermore, it is to
take into account that respiratory processes (i.e., natural
ﬂuctuations in the depth and rate of breathing and changes
in levels of carbon dioxide) can contribute substantially to
the measured BOLD signal time series, and removing their
eﬀects is an important consideration for fMRI studies of
neural function [72, 73].
Remarkably, a widespread frontotemporal lobe involve-
ment has been shown consistently in PET and fMRI studies
using both cognitive and motor tasks. For instance, cognitive
impairment was examined in a series of studies by Abrahams
et al. [12, 13], who compared rCBF during a task of executive
function (verbal ﬂuency/word generation) in patients with
impairedoﬄineverbalﬂuencyscores(ALSi)andunimpaired
oﬄine ﬂuency scores (ALSu). ALSi patients showed reduced
activation in the dorsolateral prefrontal cortex (DLPFC),
premotor cortex, insular cortex, and thalamus, conﬁrming
previous ﬁndings [8]. Moreover, Abrahams et al. [74]h a v e
also used fMRI to further assess whether word retrieval
deﬁcits and underlying cerebral abnormalities are executive
in nature, or whether they represent a language dysfunc-
tion. They compared ALS patients to matched healthy
controls during performance of two tasks: verbal ﬂuency
and confrontation naming. The ALS group demonstrated
impaired activation in the DLPFC, the anterior cingulate
gyrus, and the inferior frontal gyrus (implicated in letter
ﬂuency), in the supramarginal gyrus and the temporal lobe
auditory association areas (implicated in the phonological
store component of working memory and phonological
and lexical processing, resp.), and in the occipitotemporal
pathway (involved in confrontation naming).
PET and fMRI studies associated with motor tasks have
been consistently applied to investigate cortical reorganiza-
tion of the motor system. In fact, Kew et al. [9], for the
ﬁrst time, demonstrated that ALS patients performing a
stereotyped and self-generated PET motor task showed
markedactivationabnormalitiesinsensorimotor,parietalas-
sociation, and anterior cingulate cortices. More recent fMRI
studies conﬁrmed these ﬁndings about the cortical plasticity
in ALS [75, 76]. Moreover, to assess the eﬀects of motor
neuron degeneration on both cortical and subcortical areas,
Tessitore et al. [77] conducted an fMRI study while a
group of ALS patients performed a simple visually paced
motor task. In comparison to controls, patients with ALS
exhibited reduced activity in the right parietal association
cortex, involved in the execution of visually guided move-
ments and strongly connected to the cortical motor area,
and heightened activity in the left anterior putamen, also
implicated in motor execution. When comparing patients
with greater UMN involvement to patients with greater
LMN involvement, there were signiﬁcant diﬀerences in the
anterior cingulate cortex and right caudate nucleus, with
more robust activation of these areas in the group with
greater UMN involvement. These results provided further
evidence for altered functional responses in brain regions
subserving motor behavior in patients with sporadic ALS,
reﬂecting previous morphometric and PET results that had
revealed signiﬁcant impairment of extra-motor regions such
as the prefrontal and parietal cortices [46, 67, 68].
The increased striatal activation in patients with ALS
was interpreted as a compensatory response to increasing
functional demands in the context of aﬀected cortical motor
areas, even during the execution of a simple motor task.
Therefore, the striatal pattern of activation may indicate the
need of the ALS patient group to recruit the basal ganglia
system (normally recruited in adaptive control of more
complex motor behaviors) as a compensatory circuitry to
perform simple motor tasks as well as controls. This ﬁnding
was consistent with previous PET results concerning an
abnormal recruitment of nonprimary motor areas in ALS
[9], also interpreted as a pattern of functional adaptation
to the corticospinal tract (CST) dysfunction. Thus, it has
been suggested that such increased activation during motor
tasks may reﬂect cortical plasticity, as new synapses and
pathways are developed to compensate for the selective loss
of pyramidal cells in the motor cortex [76] with consequent
proliferationofsynapticprocessesinlessaﬀectedbrainareas.
Signiﬁcantly, patterns of functional adaptation were also
detectedinALSbyneurophysiologicalﬁndings,derivedfrom
electroencephalography (EEG) and magnetoencephalogra-
phy (MEG) studies [78, 79], and in case of motor recovery
after ischemic stroke [80], in other neurodegenerative disor-
ders [81, 82], and in the aging brain [83].
Further evidence of cortical adaptive changes in the
aﬀected brain of ALS patients is derived from fMRI studies
that investigated random hand movements against rest [84].
Once again during such a motor task, patients with ALS
showed increased cortical activation bilaterally, extending
from the sensorimotor cortex posteriorly into the inferior
parietal lobule and inferiorly to the superior temporal gyrus.
In addition, ALS patients showed reduced activation in the
DLPFC extending to anterior and medial frontal cortex [84].
More recently, to assess fMRI longitudinal data on
activation changes in diﬀerent clinical stages of the disease,
Mohammadi et al. [85] investigated motor activations in
three groups of ALS patients with diﬀerent degrees of weak-
ness, and a subset of those patients was scanned on mul-
tiple occasions. Two distinct stages of neuroplastic changes
were identiﬁed: ﬁrst, an increase of the activated area in
contralateral sensorimotor cortex, and second, a reductionNeural Plasticity 5
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Figure 1: Sensorimotor network (SMN) in the healthy controls (a) and ALS patients (b) groups that Tedeschi et al. [28] examined by
RS-fMRI (independent component analysis, ICA). The amount of coherent RS-fMRI ﬂuctuations within this network appeared strongly
reduced in the ALS population.
of signal change and beta weights with increasing weakness.
The increase of the activated area was interpreted as a
result of decreased intracortical inhibition, which seems
to play a determinant role in regulating plasticity in both
neurodevelopmental and neurodegenerative disorders [64,
65], and the reduction of movement-related signal change
and beta weights as a consequence of loss of upper motor
neurons.
A novel focus of neuroimaging research concerns the
analysis of functional connectivity of spatially remote brain
regions. To this purpose, the whole-brain analysis of func-
tional connectivity by RS-fMRI appears important in devel-
oping a better understanding of speciﬁc motor or cognitive
functions by exploring highly reproducible networks at
rest, the so-called resting-state networks (RSNs) [27, 86].
Theoretically, during rest there exist spontaneous coherent
ﬂuctuations of the BOLD signal in diﬀerent brain areas that
are functionally connected.
Mohammadi et al. [87] examined, for the ﬁrst time, the
RSNs activity in ALS and demonstrated signiﬁcant changes
in the sensorimotor network (SMN), mainly the premotor
area (Brodmann area-BA 6). In addition, in comparison to
healthy controls, ALS patients demonstrated a signiﬁcantly
weaker connectivity of the default mode network (DMN)
in the ventral anterior cingulate cortex, posterior cingulate
cortex, and the left and right inferior parietal cortex, regions
that have been linked to higher level executive functions.
Indeed, this ﬁnding would support previous neuropsycho-
logical evidences of a dysexecutive syndrome in ALS patients
[2–4, 8, 10, 63].
Later, Tedeschi et al. [28] designed an RS-fMRI study
in ALS not only to assess functional RSNs but also to
examinethepossibleinteractionbetweenneurodegeneration
and aging, which has been reported to induce physiological
age-related modulation eﬀects on fMRI signal ﬂuctuations
especially in the DMN [88, 89]. The amount of coherent
RS-fMRI ﬂuctuations within the SMN network appeared
strongly and signiﬁcantly reduced in the ALS population
especiallyinprimarymotorcortex(PMC)regions(Figure1),
in agreement with those reported by Mohammadi et al.
[87]. Furthermore, the frontoparietal network (FPN), which
includes the main RSNs in the cognitive domain, presented
a selective suppression of signal ﬂuctuations in ALS patients
in two clusters of the right FPN (the superior frontal gyrus
and the supramarginal gyrus). These eﬀects in a cognitive
executive network like the right FPN are consistent with the6 Neural Plasticity
frontal executive dysfunction that has been largely described
in ALS [2–4].
Remarkably, in the ALS patient group there was a sta-
tistically signiﬁcant interaction between neurodegeneration
and aging (disease-by-age eﬀect) in the DMN, speciﬁcally,
in the posterior cingulate cortex (PCC). In fact, this eﬀect
resultedcapableofinverting thetrendofnegativecorrelation
between functional connectivity and age observed in the
sex- and age-matched control group. This ﬁnding is in line
with recent evidence that neurodegenerative dementias may
be associated with increased functional connectivity within
unaﬀected (or aﬀected at later stages) networks with less
evident functional decline [90, 91]. Particularly, posterior
cortical functions have been shown to survive or even thrive
in patients with FTD [92, 93] in contrast to Alzheimer’s
disease that, like normal aging, damages the posterior part
of the DMN [94].
Interestingly, the positive modulation on the sponta-
neous functional connectivity of the posterior part of DMN
described by Tedeschi et al. [28]i na nA L Sp o p u l a t i o na p -
pears to be similar to the RS-fMRI trend observed in the
behavioral variant of FTD [94] and may be interpreted as
the functional expression of a possible compensatory mech-
anism of the default system to the combined eﬀect of de-
generation and aging. However, a recent study using animal
and cellular models of ALS pathophysiology [95] has linked
neurodegeneration and aging to speciﬁc strategies of neuro-
protectionbywhichthecelldamageiscontrastedwithadapt-
ive mechanisms against the physiological stress implied by
aging.
5. StructuralNeuroimaging
Morphometric studies by volumetric MRI were originally
used in ALS for the in vivo investigation of region-speciﬁc
volume reductions and have enabled the detection of subtle
yet signiﬁcant cortical and subcortical changes in the frontal
and temporal lobes [96, 97].
In recent years, the development of advanced automated
imaging analysis, based upon construction of statistical
parametric maps, allowed detailed anatomic studies of
brain morphometry. Particularly, voxel-based morphometry
(VBM) allows a fully automated whole-brain measurement
of regional brain atrophy by voxelwise comparison of gray
matter (GM) and white matter (WM) volumes between
groups of subjects [98]. The most consistent ﬁnding of VBM
studies in ALS involves GM atrophy in several regions of
the frontal (i.e., the anterior cingulate, middle and inferior
frontal gyrus, BA 8, 9, and 10) and temporal lobes (i.e.,
temporal poles, superior temporal gyrus, temporal isthmus)
[14–17, 28, 99].
Among the authors who investigated GM volumetric
changes in ALS, Mezzapesa et al. [15] and Grossman et al.
[16] reported signiﬁcant correlations between measures of
cognitive function and cortical atrophy in classical ALS
patients.
Mezzapesa et al. [15] detected a gray matter volume
decrease in several frontal and temporal areas bilaterally
in patients with ALS, whose performances on Symbol
Digit Modalities Test were signiﬁcantly worse compared
with controls. Therefore, the presence of mild whole-brain
volume loss and regional frontotemporal atrophy seemed to
be related to the cognitive impairment in patients with ALS.
Grossman et al. [16] showed atrophy in several regions
including the frontal, temporal, limbic, and occipital lobes.
From a neuropsychological point of view, patients showed
signiﬁcantdiﬃcultyonmeasuresrequiringactionknowledge
compared to object knowledge, and performances to this
kind of tasks were highly correlated with cortical atrophy in
motor regions. Interestingly, scores on tests of both action
and object knowledge were correlated with decreased GM
volume in inferior frontal cortex and DLPFC, known to
be involved in components of semantic memory. Therefore,
deﬁciency in semantic access in patients with ALS partially
reﬂects the degeneration of motor system mediation of
tasks requiring knowledge of action features, while also
reﬂecting degeneration of prefrontal regions responsible for
both action and object knowledge.
To identify a marker of upper motor neuron degenera-
tion, a surface-based cortical morphology technique has also
been applied in ALS measuring cortical thickness, surface,
and volume. Cortical morphology analyses revealed speciﬁc
thinning in the precentral gyrus (preCG) [21, 100, 101]c o r -
related with CST damage evaluated by DTI in combined
analyses [21, 100]. A signiﬁcant direct association was not
found between measures of cortical thickness and cognitive
impairment, although relative thinning in temporal regions
was associated with a rapidly progressive disease course
[101].
DTI studies of ALS have developed along two main
directions: (i) a voxel-by-voxel evaluation of whole-brain
WM and (ii) measurements of speciﬁc tracts by positioning
regions of interest (ROIs). The ﬁrst type of analysis involves
the coregistration of each person’s scan to a common tem-
plate and can be performed without an a priori hypothesis.
With this method, anisotropy maps are coregistered into a
standard space, allowing comparisons of anisotropy value
between groups. Moreover, this approach based on whole-
brain DTI analysis may result in higher accuracy in detecting
widespread microstructural disease-related WM changes
rather than by using an ROI-based method.
Recent whole-brain DTI analyses reported regions of
WM damage in ALS via voxel-based [17–19, 23, 102, 103],
tract-based spatial statistics (TBSS) [18, 20, 22, 24, 104], and
High Angular Resolution Diﬀusion Imaging (HARDI) [25]
approaches.Mostofthesestudiesfoundchangesoffractional
a n i s o t r o p y( F A )a n dm e a nd i ﬀusivity (MD) not only in the
CSTsbutalsointhecorpuscallosum[18,20,23,24,102]and
the frontal and temporal lobes [17, 18, 23, 29].
Recently, new insights in the assessment of corticomotor
connectivity changes in ALS were obtained by acquiring
HARDI scans along with high-resolution structural images
(sMRI) [25]. A signiﬁcant reduction in mean FA within a
number of intra- and interhemispheric WM connections
associated with the preCG and postcentral (postCG) gyri
was found in ALS participants compared to controls, inNeural Plasticity 7
P<0.001
corrected
P<0.05
corrected Superior longitudinal fasciculus Uncinate fasciculus
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Figure 2: Regional FA reductions in ALS patients compared with healthy controls in frontal (associative) tracts (TBSS DTI analysis
performed by Cirillo et al. [24]). In (a), blue shows the superior longitudinal and the uncinate fasciculi (derived from the Johns Hopkins
University White-Matter Tractography atlas [106, 107]), whilst red shows signiﬁcant FA decrease in ALS patients (P<0.05, corrected). (b)
illustrates 3D renderings of the FA skeleton (green), where white shows regional FA reductions in patients. Remarkably, these diﬀusivity
changes resemble those which have been described in patients with the behavioral variant of frontotemporal dementia.
agreement with other DTI analyses (i.e., FA decrease in ante-
rior cingulate, superior longitudinal, inferior longitudinal,
inferior occipitofrontal, and uncinate fasciculi) (Figure 2)
[24, 25]. Once again this DTI pattern of predominantly
frontal WM injury clearly reﬂects the frontal executive
dysfunction that has been extensively described in several
cohorts of patients with ALS [2, 3] and is consistent with
similar diﬀusivity changes described in patients with the
behavioral variant of FTD [105].
By combining DTI and graph analytical network
approaches (examination of the organization of widespread
functional brain networks or connectome), Verstraete et al.
[29] found a signiﬁcantly impaired structural network over-
lapping bilateral primary motor regions (precentral gyrus
andparacentrallobule,BA4),bilateralsupplementarymotor
regions (caudal middle frontal gyrus, BA 6), parts of the left
basal ganglia (pallidum), and right posterior cingulate and
precuneus in ALS. Therefore, the neurodegeneration process
seems to aﬀect not only the primary motor connections
but also the connectivity between primary motor regions
and supplemental motor areas. The authors hypothesize that
the disease starts in the precentral gyrus and progresses
along the structural connections of the primary motor
regions towards secondary motor regions, as suggested by
both DTI [20, 24] and graph analytical network evidence.
Alternatively, brain plasticity might be potentially attributed
to the reduced motor connectivity. This takes into account
that the connectivity changes reported in DMN in ALS
patients [28, 87] were in agreement with the ﬁndings of
impaired structural connectivity of the motor network to the
precuneus and PCC, key regions of the DMN.
To investigate the functional correlates of the structural
changes, combined MRI studies have been recently per-
formed in ALS. A multiparametric analysis by Verstraete et
al. [21], based on a network perspective, by combining cor-
tical thickness, DTI and RS-fMRI techniques, demonstrated
a decline of structural integrity (i.e., signiﬁcant reduction
of cortical thickness in the preCG and in microstructural
organization of rostral CST) with preserved functional
organization of the motor network in ALS (Figure 3).
Moreover, the local connectedness was found to be related
with disease progression. Accordingly with these results,8 Neural Plasticity
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Figure 3: (a) Cortical thickness (CT) in patients with ALS versus controls in the preCG in mm (P = 0.04), corrected for age and whole
brain CT. (b) Fractional anisotropy (FA) values along the CST and the corpus callosum, evaluated by DTI analysis, in patients with ALS and
controls (∗∗P<0.01; ∗P<0.05). (c) Number of functional connections in patients with ALS versus controls, corrected for age (threshold
0.40) (P = 0.14): this result was indicative of a relative sparing of functional connectivity in patients (derived from Verstraete et al. [21]).
another MRI study of connectivity in ALS by Douaud et al.
[22] demonstrated an increased functional connectivity
directlyassociatedwithanimpairedALS-speciﬁcgreymatter
network (predeﬁned by the consistent regions of WM
damage), spanning sensorimotor, premotor, prefrontal, and
thalamic regions (Figure 4). Patients with a slower rate
of disease progression (not only longer disease duration)
presented connectivity values more comparable to those
of healthy controls. Therefore, these ﬁndings prompted
speculation as to whether connectivity changes might have
a more active role in pathogenesis. In fact, one hypothesis is
thatincreasedfunctionalconnectivityarisesasaresultofloss
of central nervous system interneurons inﬂuence, reﬂected
in the hitherto unexplained variable compartmentaliza-
tion of pathology within upper and lower motor neuron
populations [108]. This interneuronopathy may cause a
generalized hyperexcitability in the motor cortex, as also
shown by several electrophysiological ﬁndings (i.e., derived
from transcranial magnetic stimulation or TMS, and event-
related potentials or ERP studies) [109–111], and appears
also corroborated by histopathological [41] and ﬂumazenil
PET [67, 68]e v i d e n c e .
Studies of lower motoneurons in the animal model of
the disease have given important clues to the downstream
mechanismsofcelldeathinthespinalcord,wheretheearliest
damage appears to occur in the interneurons in lamina VII
known as Renshaw cells [112]. It was then hypothesized that
dysfunction or loss of Renshaw cells may have important
consequences for spinal connectivity and motor control.
Speculatively therefore, an excitotoxic pathway common to
upper and lower motor neurons populations might result
from an unopposed glutamatergic activity [108]. However,
abnormal presymptomatic development of lower motor
neuron connectivity has not been seemed a prerequisite for
subsequent neuromuscular pathology in a mouse model of
severe spinal muscular atrophy (SMA) [113].
Finally, an era of multimodal MRI studies, combining
several advanced techniques, along with neuropsychological,
genetic, and histopathological information, might lead to
a comprehensive assessment of neurodegeneration in ALS,
including disease mechanisms and monitoring of disease
progression and therapeutics. Remarkably, with the model
of Alzheimer’s Disease Neuroimaging Initiative (ADNI)
[114] in mind, Oxford University (UK) hosted international
scientists at the ﬁrst Neuroimaging Symposium in ALS
(NISALS; November 2010), which led to the development of
consensus guidelines on image acquisition and analysis, with
the aim of retrospective data sharing to further explore the
feasibility of MRI as a surrogate marker in future therapeutic
trials for ALS [69].Neural Plasticity 9
Figure 4: Increase of functional connectivity and lower structural connectivity in a population of ALS patients studied by Douaud et
al. [22]. The spatial distribution of the signiﬁcant increase of functional connectivity in patients (red-yellow scale: P<0.05, corrected)
corresponded to the areas where the patients had lower structural connectivity, evaluated by using tract-based spatial statistics and
probabilistic tractography, in comparison to healthy controls (in blue, thresholded at 10 streamlines of diﬀerence on average) (derived
from Douaud et al. [22]). By permission of Oxford University Press.
6. Concluding Remarks
The involvement of frontotemporal areas in ALS and the
existence of overlap syndromes with dementia types have
been recognized for decades. Functional imaging studies
have conﬁrmed that functional changes beyond the primary
motor network are a common feature in ALS patients and
mayreﬂectanattemptoftheALSbraintocompensateforthe
eﬀectofmotorneurodegenerationbyneuralplasticitywithin
unaﬀected or less aﬀected structures subserving cognitive
domains.Alternatively,theabnormalfunctionalconnectivity
may arise as a result of loss of interneurons inhibitory
inﬂuence, with widespread and variable eﬀects on upper and
lower motor neuron populations.
We believe that future studies based on neuropsychology,
advanced imaging, molecular pathology, and genetics will
further enhance our understanding of the relationship
between motor system dysfunction and cognition and
provide valuable information on the physiopathological
mechanismsunderlyingthecomplexinteractionbetweenthe
multiple aﬀected systems in ALS.
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